Literature DB >> 19352054

A case of hypothalamic panhypopituitarism with empty sella syndrome: case report and review of the literature.

Hisako Komada1, Masaaki Yamamoto, Saki Okubo, Kanto Nagai, Keiji Iida, Takehiro Nakamura, Yushi Hirota, Kazuhiko Sakaguchi, Masato Kasuga, Yutaka Takahashi.   

Abstract

Empty sella syndrome is frequently accompanied with pituitary dysfunction. Most of the patients with empty sella syndrome demonstrate primary pituitary or stalk dysfunction and few cases show hypothalamic dysfunction. A 71-year-old man manifested appetite loss, nausea and vomiting with hyponatremia and adrenal insufficiency. Hormonal evaluation and cranial MRI revealed a panhypopituitarism with empty sella. Intriguingly, while the response of ACTH to CRH administration was exaggerated, the response to insulin hypoglycemia was blunted. Serum PRL levels were normal. Further, decreased level of fT4, slightly elevated basal levels of TSH, and delayed response of TSH to TRH administration were observed. These findings strongly suggest that the panhypopituitarism is caused by hypothalamic dysfunction. The presence of autoantibodies to pituitary and cerebrum in the patient's serum implies an autoimmune mechanism as a pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19352054     DOI: 10.1507/endocrj.k08e-214

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  2 in total

1.  From pituitary expansion to empty sella: disease progression in a mouse model of autoimmune hypophysitis.

Authors:  Isabella Lupi; Jiangyang Zhang; Angelika Gutenberg; Melissa Landek-Salgado; Shey-Cherng Tzou; Susumu Mori; Patrizio Caturegli
Journal:  Endocrinology       Date:  2011-08-23       Impact factor: 4.736

2.  A Case Report of Late Onset Mania Caused by Hyponatremia in a Patient With Empty Sella Syndrome.

Authors:  Chung-Hao Yang; Yu-Chen Lin; Po-Han Chou; Hung-Chieh Chen; Chin-Hong Chan
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.